For complete automation of the fed-batch mammalian cell culture process, the control of glucose - a key nutrient source - is critical.
Icq consultants manual#
The automation of manual processes is a rapidly advancing trend in the biopharmaceutical industry. The first portfolio product, the Advanced Control Bioreactor System BR1000 was recently released on January 8, offering significant performance advantages over existing methods for biologics development. As part of this partnership agreement, Yokogawa will leverage ICQ Consultants’ engineering and laboratory expertise in the biopharmaceutical segment to deploy its new bioprocess technologies in the United States.
Since 2007, ICQ Consultants has played an important role in the commissioning and qualification of manufacturing plants in the major life sciences hubs in the United States, including some of the world’s largest biomanufacturing facilities.
These investments have driven demand for infrastructure in developing and manufacturing monoclonal antibody drugs and products that require mammalian cell bioreactor technologies. Yokogawa’s Advanced Control Bioreactor System BR1000 (Photo: Business Wire)Īs a result of the COVID pandemic, the global biopharmaceutical market has been growing at an unprecedented rate, with significant investments being made in diagnostics, vaccine development, and medical devices to test and treat the coronavirus.
0 kommentar(er)
